Letter from the President
It is hard to believe that 2011 is coming to an end! Where did another year go so quickly?
Welcome to the last edition of “The Innovator” for 2011.
Since the last edition of “The Innovator”, we have produced several more incredible events, released the 2011 Life Science Economic Impact Report for Washington state, scontinue to support dozens of life science start-up companies with our Commercialization efforts, and continue to focus on growing life sciences in Washington through our Policy efforts!
In October, we hosted the 5th Venture-Investor & Partnering (VIP) Forum this year, featuring Bayer Healthcare. Nearly 100 interested parties came to hear our guests from Bayer present an overview of how to partner with them. Then nearly 20 companies and researchers met with their business and scientific leaders 1:1 in what was one of our busiest VIP Forums to date. In order to let our hair down, we hosted this year’s 3rd Pub Night at the Pan Pacific. It was wall-to-wall with WBBA members, in what was a very enjoyable evening. WINGS was next, in what is turning out to be a very successful initiative! The discussion at the Stem Cell & Regenerative Medicine event at UW’s Institute for Stem Cell and Regenerative Medicine was outstanding, as was the discussion at Translational Medicine: From Bench to Bedside.
November was no less busy! I headed east of the mountains for our annual Tri-Cities Life Science overview in Kennewick, and then up to Vancouver, BC to speak to the Life Science BC leadership about some of our programs that we are running south of the border. In what is one of our largest events of the year, “The Governor’s Life Sciences Summit and Annual Meeting”, we welcomed more than 750 life science leaders from around the state to hear the Governor speak about why Life Sciences is such an important sector for Washington’s current and future economy. We also heard from some of the sectors most influential leaders, including; Eli Lilly’s CEO, Philips Ultrasound’s General Manager, UW’s new President, as well as the Washington Global Health Alliance and Life Science Discovery Fund. It was a tremendous turnout, discussion and event. Another highlight of the event was the release of the 2011 Life Science Economic Impact Report. Life sciences in Washington continues to be one of the state’s real economic highlights and growth sectors. Be sure to read it if you have not already!
After a full and very busy year and month, we were all ready for Thanksgiving, and spending some time with our family and friends. I am thankful for a great staff, a great job representing a great industry and, last but not least, tremendous members!
December is still quite busy, with our annual HR Committee luncheon, our final Pub Night, and Board meeting of the year and, not to mention, that we are sneaking a move to our new offices this month as well. We are all very excited about the new space, and look forward to seeing all of you there during some of our many events in 2012.
Our members have purchased nearly $30M through the WBBA’s Purchasing Partners, saving more than $4M! In this economy, that is not insignificant. We continue to speak with other potential partners, and try to ensure that our members are taking advantage of these program.
Our commercialization team has been working hard to assist and grow our life sciences start-up community. So far in 2011, 55 new start-ups have sought expert counsel from the WBBA. WINGS, VIP Forums and www.lifesciencestartup.com continue to be critical elements to our growing entrepreneurial community.
In addition to our pro-bono consulting services, the WBBA has partnered with the City of Seattle’s Office of Economic Development to “GrowSeattle” – an initiative to grow life science businesses and retain jobs to create a sustainable Seattle economy. We’ve also been awarded a Washington State CERB grant to support medical technology product exports. The WBBA, University of Washington’s C4C, and the Washington Global Health Alliance, are collaborating to enhance www.lifesciencestartup.com to assist direct companies trying to increase medical technology exports ex-US. Stay tuned for more updates on these programs.
23 Washington companies are included in DELOITTE FAST 500 INCLUDES 23 IN WASHINGTON, 6 IN SEATTLE, several of them are WBBA members!!!
As mentioned earlier, many of our state and federal delegates are reaching out to us and to our members to hear directly what our priorities are. It is vital that we continue to hear from you to know what key issues are of the highest priority to you. Our Government Affairs Committee is busy finalizing our 2012 priorities, and we will continue to work on increasing our voice in both Olympia and Washington DC.
I encourage you to go to WBBA’s Public Policy page on our website to learn more about our priorities and to get involved.
We remain dedicated to work to help our members grow and succeed, as well as to focus on our mission to grow life sciences in Washington, and to support “Innovation to realization, supporting breakthrough discoveries to better health care solutions.”
Please feel free to let us know how we can be of assistance to you, and we hope to see you in the very near future.
Return to top
Return to newsletter main page